Post Surgery Treatment Articles & Analysis
4 news found
Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck’s supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, the company’s anti-PD-1 therapy, for the treatment of patients with high-risk early-stage triple-negative breast cancer (TNBC), in combination with chemotherapy as neoadjuvant (pre-operative) ...
TISSIUM is being recognized in the Surgery of the Future category with its project, “Innovative DrugEluting Adhesive for Surgery ...
ByTISSIUM
You wish the best for your patients, and following surgery or treatment, it is imperative to understand how their bodies are reacting. ...
An article recently published in Radiology highlights the groundbreaking use of a new imaging technology introduced by Seno Medical Instruments, Inc.® (Seno Medical) to diagnose breast cancer. The technology may offer physicians a new, non-invasive tool to not only better differentiate between benign and malignant breast cancers, but may also help differentiate between breast cancer molecular ...